Related references
Note: Only part of the references are listed.Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survival
Titte R. Srinivas et al.
CLINICAL TRANSPLANTATION (2015)
Conversion From Twice-Daily to Once-Daily Tacrolimus Does Not Reduce Intrapatient Variability in Tacrolimus Exposure
Nauras Shuker et al.
THERAPEUTIC DRUG MONITORING (2015)
Pharmacokinetics and pharmacodynamics of immunosuppressive drugs in elderly kidney transplant recipients
Yun-Ying Shi et al.
TRANSPLANTATION REVIEWS (2015)
Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management
Nauras Shuker et al.
TRANSPLANTATION REVIEWS (2015)
Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure
Ruth Sapir-Pichhadze et al.
KIDNEY INTERNATIONAL (2014)
CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients
N. Spierings et al.
THERAPEUTIC DRUG MONITORING (2013)
Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics
Ajay K. Israni et al.
TRANSPLANT INTERNATIONAL (2013)
Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients: A Randomized Controlled Trial Using Electronic Monitoring
Dirk R. J. Kuypers et al.
TRANSPLANTATION (2013)
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
J. Sellares et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Intra-patient variability in tacrolimus trough concentrations and renal function decline in pediatric renal transplant recipients
Agnieszka A. Prytula et al.
PEDIATRIC TRANSPLANTATION (2012)
Impact of Tacrolimus Intraindividual Variability and CYP3A5 Genetic Polymorphism on Acute Rejection in Kidney Transplantation
Han Ro et al.
THERAPEUTIC DRUG MONITORING (2012)
CYP3A5 Genotype Is Not Related to the Intrapatient Variability of Tacrolimus Clearance
Nilufar Pashaee et al.
THERAPEUTIC DRUG MONITORING (2011)
Monitoring Nonadherence and Acute Rejection With Variation in Blood Immunosuppressant Levels in Pediatric Renal Transplantation
Margaret Hsiau et al.
TRANSPLANTATION (2011)
Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients
Ming-Ju Wu et al.
TRANSPLANTATION (2011)
High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation
Lennaert C. P. Borra et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children
Stacey M. Pollock-BarZiv et al.
PEDIATRIC TRANSPLANTATION (2010)
CYP3A5*3 Genotype Associated With Intrasubject Pharmacokinetic Variation Toward Tacrolimus in Bioequivalence Study
Jae Yong Chung et al.
THERAPEUTIC DRUG MONITORING (2010)
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation
M. Naesens et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Living donor kidney transplantation:: The effects of donor age and gender on short- and long-term outcomes
Cecilia Montgomery Oien et al.
TRANSPLANTATION (2007)
Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant
M Salvadori et al.
TRANSPLANTATION (2006)
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
CE Staatz et al.
CLINICAL PHARMACOKINETICS (2004)
Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients
CJ Hesse et al.
TRANSPLANTATION PROCEEDINGS (2002)
Post-transplant renal function in the first year predicts long-term kidney transplant survival
S Hariharan et al.
KIDNEY INTERNATIONAL (2002)
Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose
I Bekersky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects
I Bekersky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
